(GCTK)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
GlucoTrack, Inc. tibbiy texnika kompaniyasi bo'lib, Qo'shma Shtatlardagi diabetga chalingan odamlar uchun implantatsiya qilinadigan uzluksiz qon glyukozasi monitorini (CBGM) ishlab chiqishga qaratilgan. Kompaniya GlucoTrackni ishlab chiqadi, bu invaziv bo'lmagan glyukozani monitoring qilish moslamasi bo'lib, u diabet va prediabetga chalingan odamlarga quloq shang'iga biriktirilgan kichik sensor orqali og'riqsiz qon glyukozasi darajasini o'lchashga yordam beradi. Shuningdek, u GlucoTrack CBGMni ishlab chiqmoqda, bu 1-toifa diabet kasallari va insulin bilan bog'liq 2-toifa diabet kasallari uchun mo'ljallangan uzoq muddatli implantatsiya qilinadigan qon asosidagi CBGMdir. Kompaniya ilgari Integrity Applications, Inc. nomi bilan tanilgan va 2021 yil noyabr oyida GlucoTrack, Inc. nomini o'zgartirgan. GlucoTrack, Inc. 2001 yilda tashkil etilgan va Nyu-Jersi shtatining Rutherford shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Paul V. Goode Ph.D. | CEO, President & Director |
| Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| Mr. David Malka BA | Co-Founder |
| Mr. Mark Tapsak Ph.D. | Chief Scientific Officer |
| Mr. Peter C. Wulff | CFO, Treasurer & Secretary |
| Mr. Vincent Wong | Chief Operations Officer |
| Ms. Drinda Benjamin | Vice President of Marketing |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-01-29 | PRE 14A | formpre14a.htm |
| 2026-01-13 | S-3 | forms-3.htm |
| 2025-12-31 | 8-K | form8-k.htm |
| 2025-12-29 | 8-K | form8-k.htm |
| 2025-11-13 | 8-K | form8-k.htm |
| 2025-11-07 | 8-K | form8-k.htm |
| 2025-11-06 | 8-K | form8-k.htm |
| 2025-11-03 | 8-K | form8-k.htm |
| 2025-10-31 | DEFA14A | formdefa14a.htm |